Douglass Winthrop Advisors’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-2,406
| Closed | -$224K | – | 241 |
|
|
2017
Q3 | $224K | Buy |
2,406
+56
| +2% | +$5.21K | 0.01% | 235 |
|
|
2017
Q2 | $213K | Hold |
2,350
| – | – | 0.01% | 239 |
|
|
2017
Q1 | $206K | Sell |
2,350
-760
| -24% | -$66.6K | 0.01% | 236 |
|
|
2016
Q4 | $258K | Hold |
3,110
| – | – | 0.02% | 208 |
|
|
2016
Q3 | $288K | Buy |
3,110
+35
| +1% | +$3.24K | 0.02% | 202 |
|
|
2016
Q2 | $239K | Sell |
3,075
-325
| -10% | -$25.3K | 0.02% | 218 |
|
|
2016
Q1 | $280K | Hold |
3,400
| – | – | 0.02% | 189 |
|
|
2015
Q4 | $356K | Hold |
3,400
| – | – | 0.03% | 181 |
|
|
2015
Q3 | $358K | Buy |
3,400
+1,400
| +70% | +$147K | 0.03% | 185 |
|
|
2015
Q2 | $249K | Hold |
2,000
| – | – | 0.02% | 227 |
|
|
2015
Q1 | $249K | Buy |
+2,000
| New | +$249K | 0.02% | 227 |
|